News | Remote Monitoring | July 24, 2018

Biotricity Completes Alpha Version of Deep Data Remote ECG Diagnostic Solution

The Biotricity Bioflux remote ECG monitoring system.

July 24, 2018 - Diagnostic and consumer healthcare remote monitoring technology company Biotricity Inc. has completed the alpha version of its Bioflux 2.0 deep data diagnostic solution in accordance with U.S. Food and Drug Administration (FDA) arrhythmia diagnostic standards.

The company intends to leverage its new AI and deep data technology in arrhythmia analysis in its Bioflux 2.0 solution and focus on improved accuracy, faster diagnostics for patients, more efficient monitoring, and improved call center efficiency.

“We hope our deep data solution will eventually lead to near-instantaneous diagnostics, circumventing some of the current issues inherent in arrhythmia monitors, such as the delay that it takes for a physician to receive and analyze a patient report,” said Waqaas Al-Siddiq, founder and CEO of Biotricity. “If we have the ability to anticipate a problem early we may have the potential to send preventative or predictive alerts.”

Diagnostic failure rates are still relatively high with about 5 percent of adult patients misdiagnosed each year in the U.S. This totals more than 12 million people. Biotricity hopes to employ deep data science to increase the accuracy and efficiency of diagnostics, with the first implementation in its Bioflux 2.0 solution.

The company expects to complete software and hardware prototyping for its new solution and to file a FDA 510(k) clearance application by early 2019.

This device technology is part of a larger trend in remote ECG monitoring devices. Read more on these advances.

For more information: www.biotricity.com


Related Content

Feature | Remote Monitoring | By Arnaud Rosier, MD, PhD

This past spring, electrophysiology experts issued new recommendations for remote monitoring of cardiovascular ...

Home November 20, 2023
Home
News | Remote Monitoring

November 9, 2023 — According to a recent survey of healthcare providers (HCPs), 93 percent of clinicians are currently ...

Home November 09, 2023
Home
News | Remote Monitoring

July 21, 2023 — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today ...

Home July 21, 2023
Home
News | Remote Monitoring

July 11, 2023 — FIRE1 announced that the first U.S. patients have been successfully implanted with its FIRE1 System for ...

Home July 11, 2023
Home
News | Remote Monitoring

June 21, 2023 — Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream ...

Home June 21, 2023
Home
News | Remote Monitoring

June 13, 2023 — A recent study highlights that implantable cardioverter-defibrillator (ICD) patients with new-onset ...

Home June 13, 2023
Home
News | Remote Monitoring

May 8, 2023 — Ucardia, a cardiac conditioning software developer, announced today that it has reached an agreement to ...

Home May 08, 2023
Home
News | Remote Monitoring

March 28, 2023 — Royal Philips has announced its debut of Philips Virtual Care Management, a comprehensive approach to ...

Home March 28, 2023
Home
News | Remote Monitoring

December 15, 2022 — physIQ announced a novel approach to estimating maximum oxygen utilization (VO2Max) using wearable ...

Home December 15, 2022
Home
News | Remote Monitoring

December 8, 2022 — Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of ...

Home December 08, 2022
Home
Subscribe Now